NYSE:USNA USANA Health Sciences (USNA) Stock Price, News & Analysis $42.62 +0.78 (+1.86%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$41.57▼$42.9750-Day Range$41.84▼$49.7552-Week Range$40.51▼$68.00Volume73,265 shsAverage Volume90,439 shsMarket Capitalization$811.91 millionP/E Ratio13.28Dividend YieldN/APrice Target$38.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Get USANA Health Sciences alerts: Email Address USANA Health Sciences MarketRank™ Stock AnalysisAnalyst RatingHold2.00 Rating ScoreUpside/Downside10.8% Downside$38.00 Price TargetShort InterestHealthy2.63% of Float Sold ShortDividend StrengthN/ASustainability-2.08Upright™ Environmental ScoreNews Sentiment-0.17Based on 31 Articles This WeekInsider TradingSelling Shares$1.46 M Sold Last QuarterProj. Earnings Growth20.16%From $2.48 to $2.98 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.10 out of 5 starsMedical Sector391st out of 936 stocksMedicinals & Botanicals Industry3rd out of 12 stocks 1.0 Analyst's Opinion Consensus RatingUSANA Health Sciences has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageUSANA Health Sciences has only been the subject of 1 research reports in the past 90 days.Read more about USANA Health Sciences' stock forecast and price target. Previous Next 3.0 Short Interest Percentage of Shares Shorted2.63% of the float of USANA Health Sciences has been sold short.Short Interest Ratio / Days to CoverUSANA Health Sciences has a short interest ratio ("days to cover") of 3.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in USANA Health Sciences has recently increased by 5.86%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldUSANA Health Sciences does not currently pay a dividend.Dividend GrowthUSANA Health Sciences does not have a long track record of dividend growth. Previous Next 3.0 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreUSANA Health Sciences has received a 29.02% net impact score from Upright. The largest positive contribution comes from its "Nutrition" impact, which is mostly driven by its "Direct selling of nutritional products through representatives", "Direct selling of dietary supplements through representatives", and "Direct selling of skincare products through representatives" products. See details.Environmental SustainabilityThe Environmental Impact score for USANA Health Sciences is -2.08. Previous Next 1.0 News and Social Media Coverage News SentimentUSANA Health Sciences has a news sentiment score of -0.17. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.62 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 31 news articles for USANA Health Sciences this week, compared to 3 articles on an average week.MarketBeat FollowsOnly 1 people have added USANA Health Sciences to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, USANA Health Sciences insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,458,098.00 in company stock.Percentage Held by InsidersOnly 0.33% of the stock of USANA Health Sciences is held by insiders.Percentage Held by Institutions54.25% of the stock of USANA Health Sciences is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about USANA Health Sciences' insider trading history. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for USANA Health Sciences are expected to grow by 20.16% in the coming year, from $2.48 to $2.98 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of USANA Health Sciences is 13.28, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 142.19.Price to Earnings Ratio vs. SectorThe P/E ratio of USANA Health Sciences is 13.28, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 152.08.Price to Earnings Growth RatioUSANA Health Sciences has a PEG Ratio of 1.41. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioUSANA Health Sciences has a P/B Ratio of 1.58. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about USANA Health Sciences' valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Crypto 101 MediaNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has led to a massive bull run in the year after it happens. That means we're in the "golden window" right now…Check out the new "Crypto Bull Run Millionaire Blueprint" now! About USANA Health Sciences Stock (NYSE:USNA)USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.Read More USNA Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart USNA Stock News HeadlinesJuly 26 at 7:20 AM | americanbankingnews.comDA Davidson Trims USANA Health Sciences (NYSE:USNA) Target Price to $38.00July 26 at 2:28 AM | americanbankingnews.comUSANA Health Sciences (NYSE:USNA) Cut to "Buy" at StockNews.comJuly 27, 2024 | WealthPress (Ad)This TSLA short trade is on a nine win hot streakMost Tesla Shareholders are disappointed in the stock's performance in 2024. Year to date, it's down 30%... And things don’t seem to be getting better. That said, one professional trader has found a way to turn Tesla’s demise into a flurry of opportunity… In fact, he has not lost a single trade on Tesla this year. As of this mailing he’s 9 for 9 with incredible wins under his belt. Just see for yourself.July 25 at 9:04 AM | americanbankingnews.comQ3 2024 EPS Estimates for USANA Health Sciences, Inc. Reduced by Analyst (NYSE:USNA)July 25 at 7:16 AM | finance.yahoo.comWhy USANA (USNA) Shares Are Plunging TodayJuly 25 at 3:05 AM | gurufocus.comQ2 2024 USANA Health Sciences Inc Earnings Call TranscriptJuly 25 at 1:42 AM | americanbankingnews.comUSANA Health Sciences (NYSE:USNA) Reaches New 1-Year Low Following Weak EarningsJuly 24 at 10:05 AM | americanbankingnews.comUSANA Health Sciences (NYSE:USNA) Issues Quarterly Earnings ResultsJuly 27, 2024 | WealthPress (Ad)This TSLA short trade is on a nine win hot streakMost Tesla Shareholders are disappointed in the stock's performance in 2024. Year to date, it's down 30%... And things don’t seem to be getting better. That said, one professional trader has found a way to turn Tesla’s demise into a flurry of opportunity… In fact, he has not lost a single trade on Tesla this year. As of this mailing he’s 9 for 9 with incredible wins under his belt. Just see for yourself.July 23, 2024 | markets.businessinsider.comUSANA Health Sciences is about to announce its earnings — here's what to expectJuly 23, 2024 | marketwatch.comUSANA Health Sciences Shares Fall 6.4% After Cut to 2024 Sales, EPS GuidanceJuly 23, 2024 | markets.businessinsider.comUSANA Health Sciences Q2 Profit Retreats, Misses EstimatesJuly 23, 2024 | theglobeandmail.comUSANA (NYSE:USNA) Misses Q2 Revenue EstimatesJuly 23, 2024 | businesswire.comUSANA Health Sciences Reports Second Quarter 2024 ResultsJuly 22, 2024 | msn.comUSANA Health Sciences Q2 2024 Earnings PreviewJuly 22, 2024 | finance.yahoo.comUSANA (USNA) Reports Q2: Everything You Need To Know Ahead Of EarningsJuly 21, 2024 | americanbankingnews.comUSANA Health Sciences (USNA) Set to Announce Quarterly Earnings on TuesdayJuly 17, 2024 | prnewswire.com284 USANA-Sponsored Athletes in 2024 Summer Olympic and Paralympic GamesSee More Headlines Receive USNA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for USANA Health Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings7/23/2024Today7/27/2024Next Earnings (Estimated)10/22/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Medicinals & botanicals Sub-IndustryPersonal Products Current SymbolNYSE:USNA CUSIP90328M10 CIK896264 Webwww.usana.com Phone(801) 954-7100Fax801-954-7300Employees1,800Year FoundedN/APrice Target and Rating Average Stock Price Target$38.00 High Stock Price Target$38.00 Low Stock Price Target$38.00 Potential Upside/Downside-10.8%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)$3.21 Trailing P/E Ratio13.28 Forward P/E Ratio17.19 P/E Growth1.5Net Income$63.79 million Net Margins6.29% Pretax Margin10.79% Return on Equity11.13% Return on Assets8.83% Debt Debt-to-Equity RatioN/A Current Ratio4.03 Quick Ratio3.20 Sales & Book Value Annual Sales$921.01 million Price / Sales0.88 Cash Flow$4.22 per share Price / Cash Flow10.11 Book Value$26.89 per share Price / Book1.58Miscellaneous Outstanding Shares19,050,000Free Float18,988,000Market Cap$811.91 million OptionableOptionable Beta0.90 These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Key ExecutivesMr. Kevin G. Guest (Age 61)Executive Chairman Comp: $1.08MMr. Jim Brown (Age 55)CEO & President Comp: $910.73kMr. G. Douglas Hekking (Age 54)Chief Financial Officer Comp: $638.34kMr. Walter Noot (Age 58)Chief Operating Officer Comp: $623.77kMr. P. Joshua Foukas (Age 48)Chief Legal Officer, General Counsel & Corporate Secretary Comp: $561.28kMr. Daniel A. Macuga Jr. (Age 54)Chief Communications & Marketing Officer Comp: $563kDr. Myron W. Wentz (Age 83)Founder & Chairman Emeritus Dr. John CuomoExecutive Director of Product Development & TechnologyDr. Robert A. Sinnott M.N.S. (Age 59)Ph.D., Chief Scientific Officer Mr. Patrique RichardsExecutive Director of Investor Relations & Business DevelopmentMore ExecutivesKey CompetitorsHerbalifeNYSE:HLFNu Skin EnterprisesNYSE:NUSNature's Sunshine ProductsNASDAQ:NATRMedifastNYSE:MEDVeruNASDAQ:VERUView All CompetitorsInsiders & InstitutionsBank of New York Mellon CorpBought 5,205 shares on 7/26/2024Ownership: 0.511%Assenagon Asset Management S.A.Bought 27,053 shares on 7/18/2024Ownership: 0.574%SG Americas Securities LLCBought 7,522 shares on 7/12/2024Ownership: 0.039%CWM LLCSold 526 shares on 7/10/2024Ownership: 0.005%Harbor Capital Advisors Inc.Sold 3,047 shares on 7/9/2024Ownership: 0.032%View All Insider TransactionsView All Institutional Transactions USNA Stock Analysis - Frequently Asked Questions How have USNA shares performed this year? USANA Health Sciences' stock was trading at $53.60 at the beginning of 2024. Since then, USNA stock has decreased by 20.5% and is now trading at $42.62. View the best growth stocks for 2024 here. How were USANA Health Sciences' earnings last quarter? USANA Health Sciences, Inc. (NYSE:USNA) released its earnings results on Tuesday, July, 23rd. The company reported $0.54 earnings per share for the quarter, missing analysts' consensus estimates of $0.65 by $0.11. The company earned $212.87 million during the quarter, compared to the consensus estimate of $218.64 million. USANA Health Sciences had a trailing twelve-month return on equity of 11.13% and a net margin of 6.29%. What is Kevin Guest's approval rating as USANA Health Sciences' CEO? 68 employees have rated USANA Health Sciences Chief Executive Officer Kevin Guest on Glassdoor.com. Kevin Guest has an approval rating of 99% among the company's employees. This puts Kevin Guest in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. Who are USANA Health Sciences' major shareholders? Top institutional investors of USANA Health Sciences include Assenagon Asset Management S.A. (0.57%), Bank of New York Mellon Corp (0.51%), First Hawaiian Bank (0.07%) and SG Americas Securities LLC (0.04%). Insiders that own company stock include Myron W Wentz, Kevin Guest, David Mulham Mulham, Paul A Jones, John Turman Fleming, Joshua Foukas, Frederic J Winssinger, Xia Ding, Daniel A Macuga, Robert A Sinnott, Gilbert A Fuller, Brent Neidig, Walter Noot, G Doug Iiekking and Jim Brown. View institutional ownership trends. How do I buy shares of USANA Health Sciences? Shares of USNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of USANA Health Sciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that USANA Health Sciences investors own include International Business Machines (IBM), Gilead Sciences (GILD), NVIDIA (NVDA), AT&T (T), BioMarin Pharmaceutical (BMRN), Vertex Pharmaceuticals (VRTX) and AbbVie (ABBV). This page (NYSE:USNA) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredJ.P. Morgan’s DIRE WarningWhen the largest bank in the U.S. says a crisis is coming - you NEED to listen. The Wall Street Journal war...Behind the Markets | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding USANA Health Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share USANA Health Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
